Antiviral drug for post-transplant complications now costs more than the transplant
June 2, 2016
| By Mary Engel / Fred Hutch News Service
A life-saving antiviral drug used to treat a type of severe pneumonia in children and adults who have undergone bone marrow transplants can now cost more than the transplant itself after the drug’s sole distributor, Valeant Pharmaceuticals, increased the price by almost 400 percent.
The influential advocate, surgeon and survivor talks trends, treatment and ways to fast-track breast cancer research
Oct. 9, 2015
| By Diane Mapes / Fred Hutch News Service
Instantly recognizable, sometimes controversial, Dr. Susan Love may just be the most famous cancer advocate on the planet. The surgeon, researcher, activist and author talked to Fred Hutch News Service about research trends, cancer treatment and her research cohort, Army of Women.
The numbers are so vast, the hope and healing they embody seem difficult to grasp. Globally, doctors have performed more than 1 million bone marrow / stem cell transplants — a procedure pioneered at Fred Hutchinson Cancer Research Center.
Aug. 21, 2015
| By Bill Briggs
Each life saved since Dr. E. Donnall Thomas pioneered bone marrow transplantation offers untold promise. Meet Savanna Acosta, a toddler who has a full life ahead thanks to a transplant.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.